Swedish scientists retrieved RNA from an extinct Tasmanian tiger to help trace the genes that were active in the animal’s ...

A multi-omics study identifies causal genes and biological subtypes of long COVID, revealing new therapeutic targets for ...

Biologists are quietly rewriting what it means to be alive, and the human body has become one of their strangest frontiers.

A drug once designed for dengue virus, then quietly abandoned by industry, is suddenly back in the spotlight, and it may be ...

In the realm of modern medicine, RNA-based therapies have emerged as a promising avenue, with significant advancements in metabolic diseases, oncology, and preventive vaccines. A recent article ...

From a mega-nest of turtles and orcas using tools, to deep-sea sharks and 40,000-year-old mammoths, 2025 delivered some of ...

TheFly reports that on December 19, 2025, H.C. Wainwright upgraded Wave Life Sciences Ltd. (NASDAQ:WVE)’s price target from ...

Stony Brook Heart Institute’s Center for Advanced Lipid Management has achieved a historic global milestone, becoming the first center in the world to administer a commercial dose of plozasiran, the ...

Discover how AI is revolutionizing RNA drug development in a new article published in Engineering. Learn about the potential ...

A new study published in Engineering reveals that NSUN2, a key protein involved in RNA modification, significantly ...

Researchers in Sweden recovered RNA from a 130-year-old Tasmanian tiger, allowing them to identify which genes were active in its tissues before extinction.

Sean Ryder, professor at UMass Chan Medical School, has written a book to delve the mysteries of ribonucleic acid as a tool to fight diseases. Messenger ribonucleic acid, or mRNA, is in the public ...